FDA recalls 180,000 cans of soup sold at Walmart - the-sun.com
Amy’s Kitchen is recalling over 184,000 cans of vegan lentil soup across the United States due to a can defect and spoilage risks.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Amy’s Kitchen recalled over 184,000 cans of vegan lentil soup across 27 to 28 states. The recall was issued due to a can defect that created a potential risk for spoilage.
Epilogue added 105d ago, after coverage quieted.
The brief
According to reports from People.com and NBC Bay Area, the recall is driven by a specific can defect that creates a potential for spoilage. This product safety measure follows FDA involvement, as highlighted by the-sun.com, which specifically notes that these cans were sold at Walmart. The recall effort is widespread, with Gizmodo reporting that the affected soup has been distributed across 27 states, while The Healthy @Reader's Digest indicates the reach extends to 28 states. Multiple media outlets are closely monitoring the development of this food safety event. VegNews.com classifies the recall as breaking news, specifically identifying the product as a top-selling vegan lentil soup.
Meanwhile, the Detroit Free Press is focusing on regional impact, questioning whether any of the thousands of recalled cans were sold within the state of Michigan, while USA Today is urging consumers to identify affected products. Understanding the scale of this recall is critical because the products involved are popular consumer goods sold through major retailers like Walmart. The involvement of the FDA indicates a regulatory oversight to ensure public safety against spoilage risks. Because the recall spans between 27 and 28 states, the logistics of the retrieval process are extensive. The specific nature of the 'can defect' mentioned by NBC Bay Area and People.com is the central technical cause for the removal of these vegan lentil soup items from store shelves and consumer homes.
Moving forward, consumers and retailers should monitor official lists to see the specific affected products. According to USA Today, customers are encouraged to check their inventory to see if they possess the recalled soup. Coverage from the Detroit Free Press suggests that state-level distribution details, such as those for Michigan, remain a point of inquiry.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (81% supported) Updated 114d ago.
Quick answers
How many cans of soup are being recalled?
Reports indicate that between 180,000 and 184,200 cans are being recalled.
What is the reason for the Amy's Kitchen recall?
The recall is due to a can defect that creates a potential for spoilage.
Where was the affected soup sold?
The soup was sold at Walmart and distributed across 27 to 28 states.
Coverage (8)
- BREAKING: Amy’s Recalls 184,000 Cans of Top-Selling Vegan Lentil Soup VegNews.com · 116d ago
- Thousands of cans of soup under recall. Were any sold in Michigan? Detroit Free Press · 116d ago
- Amy’s Soup Recalled in 27 States Over Spoilage Risk Gizmodo · 116d ago
- Amy’s Kitchen Recalls 184,200 Cans of Lentil Soup Due to ‘Potential for Spoilage’ from Can ‘Defect’ People.com · 116d ago
- FDA Soup Recall: 184,000 Cans in 28 States for Spoilage Worry The Healthy @Reader's Digest · 116d ago
- Over 180,000 cans of this popular soup recalled. See affected product USA Today · 116d ago
- Amy's Kitchen recalls more than 184,000 cans of soup over can defect NBC Bay Area · 116d ago
- FDA recalls 180,000 cans of soup sold at Walmart the-sun.com · 116d ago
Topics
Related trends
Roche Secures First U.S. Approval for New Breast-Cancer Pill
Roche wins FDA approval for its first U.S. oral SERD, giredestrant plus everolimus, for hormone-resistant advanced breast cancer.
These Companies Are Using Trump’s Tariff Refunds for Executive Bonuses
Major retail and technology corporations are reportedly directing federal tariff refunds toward executive bonuses instead of consumer refunds.
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Novo Nordisk reports Wegovy injection reduced BMI and obesity rates in children as young as six in a clinical trial, expanding the drug's potential pediatric use.
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
Millions of Americans are not taking their GLP-1 drugs as prescribed
Nearly half of U.S. GLP-1 users are altering prescribed dosing, with cost and side effects driving widespread non-adherence.
FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
The United States Food and Drug Administration has rejected Summit Therapeutics and Akeso's lung cancer drug ivonescimab.